ACVRL1 and hereditary hemorrhagic telangiectasia: Mutations in ACVRL1 (or endoglin) can cause the vascular disease hereditary hemorrhagic telangiectasia type 2 (HHT2) [35], which is associated with abnormal blood vessel structures and increased risk of bleedings.